Galvez, Jose J; Cardiff, Robert D; Munn, Robert J et al. (2004) Mouse models of human cancers (Part 2). Comp Med 54:13-5 |
Cvetkovic, Dusica; Pisarcik, Debra; Lee, Chan et al. (2004) Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer. Gynecol Oncol 95:449-55 |
Nikitin, Alexander Y; Connolly, Denise C; Hamilton, Thomas C (2004) Pathology of Ovarian Neoplasms in Genetically Modified Mice. Comp Med 54:26-8 |
Connolly, Denise C; Bao, Rudi; Nikitin, Alexander Yu et al. (2003) Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 63:1389-97 |
Abdollahi, Abbas; Gruver, Briana N; Patriotis, Christos et al. (2003) Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells. Biochem Biophys Res Commun 307:188-97 |
Hamilton, T C; Connolly, D C; Nikitin, A Y et al. (2003) Translational research in ovarian cancer: a must. Int J Gynecol Cancer 13 Suppl 2:220-30 |
Abdollahi, Abbas; Pisarcik, Debra; Roberts, David et al. (2003) LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J Biol Chem 278:6041-9 |
Selvakumaran, Muthu; Pisarcik, Debra A; Bao, Rudi et al. (2003) Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 63:1311-6 |
Cvetkovic, Dusica; Williams, Stephen J; Hamilton, Thomas C (2003) Loss of cellular retinol-binding protein 1 gene expression in microdissected human ovarian cancer. Clin Cancer Res 9:1013-20 |
Bao, Rudi; Selvakumaran, Muthu; Hamilton, Thomas C (2002) Targeted gene therapy of ovarian cancer using an ovarian-specific promoter. Gynecol Oncol 84:228-34 |
Showing the most recent 10 out of 28 publications